NFL BIOSCIENCES (EPA:ALNFL) | WebDisclosure

Basculer en Français

8611	Companies
141742	Keywords
77650	Articles
75757	Press releases

Home
Companies
NFL BIOSCIENCES

REGULATED PRESS RELEASE

published on 03/05/2025 at 17:45, 1 month 8 days ago

NFL Biosciences publishes its 2025 financial agenda
NFL Biosciences announces its 2025 financial agenda, including key events such as annual results and AGM. The biopharmaceutical company focuses on developing botanical drugs for addictions

NFL Biosciences Biopharmaceutical Botanical Drugs 2025 Financial Agenda Addictions
REGULATED PRESS RELEASE

published on 03/05/2025 at 17:45, 1 month 8 days ago

NFL Biosciences publie son agenda financier 2025
NFL Biosciences publie son agenda financier 2025 avec les dates clés des événements financiers et présente ses activités dans le développement de médicaments botaniques pour le traitement des addictions

NFL Biosciences Médicaments Botaniques Euronext Paris Agenda Financier Addictions
BRIEF

published on 02/04/2025 at 07:05, 2 months 9 days ago

NFL Biosciences : résultats positifs pour le traitement NFL-101

NFL-101 Sécurité Études Cliniques Addiction Au Tabac Profil Bénéfice-risque
BRIEF

published on 02/04/2025 at 07:05, 2 months 9 days ago

NFL Biosciences Highlights Safety of NFL-101 in New Study

Clinical Trials Treatment Development NFL-101 Safety Tobacco Addiction Regulatory Process
REGULATED PRESS RELEASE

published on 02/04/2025 at 07:00, 2 months 9 days ago

NFL Biosciences publie les résultats positifs d’un programme complémentaire confirmant l’excellent profil de sécurité de NFL-101, son traitement first in class contre l’addiction au tabac
NFL Biosciences publie des résultats positifs d'un programme complémentaire confirmant le profil de sécurité de son traitement NFL-101 contre l'addiction au tabac

NFL Biosciences NFL-101 Sécurité Traitement Addiction Au Tabac
REGULATED PRESS RELEASE

published on 02/04/2025 at 07:00, 2 months 9 days ago

NFL Biosciences publishes positive results from a complementary program confirming the excellent safety profile of NFL-101, its first-in-class treatment for tobacco addiction
NFL Biosciences reports positive results from toxicity study on NFL-101, showing superior safety profile for tobacco addiction treatment, enhancing potential for Phase 3 development

NFL Biosciences NFL-101 Phase 3 Development Safety Profile Tobacco Addiction
REGULATED PRESS RELEASE

published on 12/05/2024 at 08:02, 4 months 8 days ago

NFL BIOSCIENCES VALIDE L’INDUSTRIALISATION DE NFL-101 POUR LE SEVRAGE TABAGIQUE
REGULATED PRESS RELEASE

published on 12/05/2024 at 08:02, 4 months 8 days ago

NFL BIOSCIENCES VALIDATES THE INDUSTRIALIZATION OF NFL-101 FOR SMOKING CESSATION
BRIEF

published on 11/18/2024 at 17:50, 4 months 25 days ago

NFL Biosciences présente NFL-101 au congrès de tabacologie

NFL Biosciences NFL-101 Sevrage Tabagique Tabacologie Mécanisme Disruptif
BRIEF

published on 11/18/2024 at 17:50, 4 months 25 days ago

NFL Biosciences Presents NFL-101 at Tobacco Congress

NFL Biosciences Smoking Cessation NFL-101 Tobaccology Disruptive Mechanism

Accesswire

Published on 04/12/2025 at 15:45, 1 day 5 hours ago

New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CFO Julia Qian, BIOVie’s Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice Presid
Published on 04/12/2025 at 02:00, 1 day 19 hours ago

Battery X Metals Announces Provisional Patent Application with United States Patent & Trademark Office for Lithium-Ion Battery Rebalancing Technology Innovations
Published on 04/12/2025 at 00:10, 1 day 21 hours ago

Applied Minerals, Inc. Files Motion to Approve Disclosure Statement
Published on 04/12/2025 at 00:00, 1 day 21 hours ago

Ur-Energy Releases 2024 Year End Results
Published on 04/11/2025 at 23:45, 1 day 21 hours ago

Gold Terra Closes First Tranche of Financing Package with Support from Osisko Gold Royalties

View all ACCESSWIRE

EQS Group

Published on 04/11/2025 at 21:45, 1 day 23 hours ago

OPPO Unveils Agentic AI Initiative at Google Cloud Next 2025, Showcasing Innovations and Leadership in AI Experiences
Published on 04/11/2025 at 18:40, 2 days 2 hours ago

AGM 2025 - Bossard Holding AG Press Release
Published on 04/11/2025 at 18:38, 2 days 2 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/11/2025 at 18:23, 2 days 3 hours ago

EQS-Adhoc: Cherry SE: Cherry SE recognizes asset impairment for 2024; updates adjusted EBITDA margin for fiscal year 2024
Published on 04/11/2025 at 18:10, 2 days 3 hours ago

Kaufman & Broad SA: 2025, 1ST QUARTER RESULTS

Les Echos

Published on 04/11/2025 at 18:30, 2 days 2 hours ago

Reclassification of shares within the Feuillet family concert with no impact on the control of the company
Published on 04/11/2025 at 18:30, 2 days 2 hours ago

Reclassement d'actions au sein du concert familial Feuillet sans incidence sur le contrôle de la société
Published on 04/11/2025 at 18:00, 2 days 3 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/03/2025
Published on 04/11/2025 at 18:00, 2 days 3 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/03/2025
Published on 04/11/2025 at 17:50, 2 days 3 hours ago

Mise à disposition du Rapport Financier Annuel 2024

View all LES ECHOS COMFI WIRE